Gender difference in skin reactivity to purified protein derivative among carriers of HTLV-I in Japan

Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology

Volumn 22, Issue 3, 1999, Pages 302-307

  Hisada, Michie ^a,c   Stuver, Sherri O ^a   Okayama, Akihiko ^b   Mueller, Nancy E ^a  

^a HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^b UNIVERSITY OF MIYAZAKI   (Japan)

^c NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Gender difference; HTLV I; Purified protein derivative

Indexed keywords

TUBERCULIN;

ADULT; AGED; ARTICLE; CELLULAR IMMUNITY; FEMALE; GENDER; HUMAN; HUMAN T CELL LEUKEMIA VIRUS 1; HUMAN T CELL LEUKEMIA VIRUS INFECTION; JAPAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SKIN MANIFESTATION;

BACILLI; HTLV; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN T-LYMPHOTROPIC VIRUS 1;

EID: 0033390541     PISSN: 10779450     EISSN: None     Source Type: Journal    
DOI: 10.1097/00126334-199911010-00013     Document Type: Article

References (37)

1. International Agency for Research on Cancer (IARC). Human T-cell lymphotropic viruses. Monographs on the evaluation of carcinogenic risks to humans. Human immunodeficiency viruses and human T-cell lymphotropic viruses, vol. 67. Lyons: IARC, 1996: 261-390.
2. Tachibana N, Okayama A, Ishihara S, et al. High HTLV-I proviral DNA level associated with abnormal lymphocytes in peripheral blood from asymptomatic carriers. Int J Cancer 1992;51:593-5.
3. Shioiri S, Stuver SO, Okayama A, et al. Intrafamilial transmission of HTLV-I and its association with anti-Tax antibody in an endemic population in Japan. Int J Cancer 1998;74:15-18.
4. Rosen C, Park R, Sodroski J, Haseltine W. Multiple sequence elements are required for regulation of human T-cell leukemia virus gene expression. Proc Natl Acad Sci USA 1987;84:4919-23.
5. Seiki M, Inoue J, Hidaka M, Yoshida M. Two cis-acting elements responsible for posttranscriptional trans-regulation of gene expression of human T-cell leukemia virus type I. Proc Natl Acad Sci USA 1988;85:7124-8.
6. Mueller NE, Okayama A, Stuver SO, Tachibana N. Findings from the Miyazaki Cohort Study. J Acquir Immune Defic Syndr Hum Retrovirol 1996;13:S2-7.
7. Kondo T, Kono H, Miyamoto N, et al. Age-and sex-specific cumulative rate and risk of ATLL for HTLV-I carriers. Int J Cancer 1989;43:1061-4.
8. Tokudome S, Tokunaga O, Shimamoto Y, et al. Incidence of adult T-cell leukemia/lymphoma among human T-lymphotropic virus type I carriers in Saga, Japan. Cancer Res 1989;49:226-8.
9. Tajima K, The T-and B-cell Malignancy Study Group. The 4th nationwide study of adult T-cell leukemia/lymphoma (ATL) in Japan: estimates of risk of ATL and its geographical and clinical features. Int J Cancer 1990;45:237-43.
10. Kaplan JE, Osame M, Kubota H, et al. The risk of development of HTLV-I-associated myelopathy/tropical spastic paraparesis among persons infected with HTLV-I. J Acquir Immune Defic Syndr 1990;3:1096-1101.
11. Ikeda E, Ono A, Hikita N, et al. Estimated prevalence rate of HTLV-I uveitis in Chikugo. Nippon Ganka Gakkai Zasshi 1998; 102:327-32.
12. LaGrenade L, Manns A, Fletcher V, et al. Clinical, pathologic, and immunologie features of human T-lymphotrophic virus type I-associated infective dermatitis in children. Arch Dermatol 1998;134: 439-14.
13. Lucey D, Clerici M, Shearer G. Type 1 and type 2 cytokine dysregulation in human infectious, neoplastic and inflammatory diseases. Clin Microbiol Rev 1996;9:532-62.
14. Tachibana N, Okayama A, Ishizaki J, et al. Suppression of tuberculin skin reaction in healthy HTLV-I carriers from Japan. Int J Cancer 1988;42:829-31.
15. Murai K, Tachibana N, Shioiri S, et al. Suppression of delayed-type hypersensitivity to PPD and PHA in elderly HTLV-I carriers. J Acquir Immune Defic Syndr 1990;3:1006-9.
16. Yamaguchi K, Kiyokawa T, Nakada K, et al. Polyclonal integration of HTLV-I proviral DNA in lymphocytes from HTLV-I seropositive individuals: an intermediate state between the healthy carriers state and smoldering ATL. Br J Haematol 1988;68:169-74.
17. Welles SL, Tachibana N, Okayama A, et al. Decreased reactivity to PPD among HTLV-I carriers in relation to virus and hematologic status. Int J Cancer 1994;56:337-40.
18. Tokuchi S. Theory and practice of new BCG immunization program. Tokyo: The Society for Tuberculosis Prevention, 1996.
19. Breslow N, Day N. The analysis of case-control studies. In: International Agency for Research on Cancer (IARC), ed. Statistical methods in cancer research, vol 1. Lyons: IARC, 1980:15,140-6,192-242.
20. Purtilo D, Sullivan J. Immunological bases for superior survival of females. Am J Dis Child 1979;133:1251-3.
21. International Agency for Research on Cancer (IARC). Hepatitis B virus. In: Monographs on the evaluation of carcinogenic risks to humans. Hepatitis Viruses, vol 59. Lyons: IARC, 1994:45-164.
22. Chiba T, Matsuzaki Y, Abei M, et al. Multivariate analysis of risk factors for hepatocellular carcinoma in patients with hepatitis C virus-related liver cirrhosis. J Gastroenterol 1996;31:552-8.
23. Yu MC, Henderson BE. Nasopharyngeal cancer. In: Schottenfeld D, Fraumeni JF Jr. eds. Cancer epidemiology and prevention, 2nd ed. New York: Oxford University Press, 1996:603-18.
24. Glaser S, Lin R, Stewart S, et al. Epstein-Barr virus-associated Hodgkin's disease: epidemiologic characteristics in international data. Int J Cancer 1997;70:375-82.
25. Nisar M, Williams C, Ashby D, Davies P. Tuberculin testing in residential homes for the elderly. Thorax 1993;48:1257-60.
26. Wegmann T, Lin H, Guilbert L, et al. Bidirectional cytokine interactions in the maternal-fetal relationship: is successful pregnancy a Th2 phenomenon? Immunol Today 1993; 14:353-6.
27. Gill TJ. Immunity and pregnancy. CRC Crit Rev Immunol 1985; 4:201-27.
28. Grossman C, Roselle G, Mendenhall C. Possible underlying mechanism of sexual dimorphism in the immune response, fact and hypothesis. J Steroid Biochem Mol Biol 1989;34:241-51.
29. Clark J, Peterson T. Cytokine production and aging: overproduction of IL-8 in elderly males in response to lipopolysaccharide. Mech Aging Dev 1994;77:127-39.
30. Paavonen T, Anderson L, Adlerkreutz H. Sex hormone regulation of in vitro immune response. Estradiol enhances human B cell maturation via inhibition of suppressor T cells in pokeweed mitogen-stimulated cultures. J Exp Med 1981;154:1935-45.
31. Paavonen T. Hormonal regulation of immune response. Ann Med 1994;26:255-8.
32. Sutherland I. Recent studies in the epidemiology of tuberculosis based on the risk of being infected with tubercle bacilli. Adv Tuberc Res 1976;19:1-63.
33. Cantwell M, Snider D, Cauthen G, et al. Epidemiology of tuberculosis in the United States, 1985 through 1992. JAMA 1994;272: 535-9.
34. Hudelson P. Gender differentials in tuberculosis: the role of socioeconomic and cultural factors. Tuber Lung Dis 1996;77:391-400.
35. Stuver SO, Tachibana N, Okayama A, et al. Heterosexual transmission of human T cell leukemia/lymphoma virus type I among married couples in southwestern Japan: an initial report from the Miyazaki Cohort Study. J Infect Dis 1993;167:57-65.
36. Rabkin CS, Corbin DO, Felton S, et al. Human T-cell lymphotropic virus type I infection in Barbados: results of a 20-year follow-up study. J Acquir Immune Defic Syndr Hum Retrovirol 1996; 12:519-22.
37. Murphy EL, Wu Y, Ownby H, et al for the NHLBI REDS Investigators [abstract], JAIDS J Acquir Immune Defic Syndr 1999;20: A71.